Folgen
NS Duesbery
NS Duesbery
Ochsner Health
Bestätigte E-Mail-Adresse bei ochsner.org
Titel
Zitiert von
Zitiert von
Jahr
Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor
NS Duesbery, CP Webb, SH Leppla, VM Gordon, KR Klimpel, ...
Science 280 (5364), 734-737, 1998
12941998
Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo
D Huang, Y Ding, WM Luo, S Bender, CN Qian, E Kort, ZF Zhang, ...
Cancer research 68 (1), 81-88, 2008
2672008
Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase
HM Koo, M VanBrocklin, MJ McWilliams, SH Leppla, NS Duesbery, ...
Proceedings of the National Academy of Sciences 99 (5), 3052-3057, 2002
1912002
Anthrax lethal factor proteolysis and inactivation of MAPK kinase
AP Chopra, SA Boone, X Liang, NS Duesbery
Journal of Biological Chemistry 278 (11), 9402-9406, 2003
1742003
Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways
NS Duesbery, J Resau, CP Webb, S Koochekpour, HM Koo, SH Leppla, ...
Proceedings of the National Academy of Sciences 98 (7), 4089-4094, 2001
1462001
Anthrax toxins
NS Duesbery, GF Vande Woude
Cellular and Molecular Life Sciences CMLS 55, 1599-1609, 1999
1131999
BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin
RJ Abi-Habib, JO Urieto, S Liu, SH Leppla, NS Duesbery, AE Frankel
Molecular Cancer Therapeutics 4 (9), 1303-1310, 2005
952005
MEK genomics in development and disease
JL Bromberg-White, NJ Andersen, NS Duesbery
Briefings in functional genomics 11 (4), 300-310, 2012
932012
Sensitizing anthrax lethal toxin-resistant macrophages to lethal toxin-induced killing by tumor necrosis factor-α
SO Kim, Q Jing, K Hoebe, B Beutler, NS Duesbery, J Han
Journal of Biological Chemistry 278 (9), 7413-7421, 2003
892003
Identification of VEGF-independent cytokines in proliferative diabetic retinopathy vitreous
JL Bromberg-White, L Glazer, R Downer, K Furge, E Boguslawski, ...
Investigative ophthalmology & visual science 54 (10), 6472-6480, 2013
772013
Anthrax lethal factor causes proteolytic inactivation of mitogen‐activated protein kinase kinase
NS Duesbery, GFV Woude
Journal of applied microbiology 87 (2), 289-293, 1999
671999
Anthrax toxin-induced shock in rats is associated with pulmonary edema and hemorrhage
SR Kuo, MC Willingham, SH Bour, EA Andreas, SK Park, C Jackson, ...
Microbial pathogenesis 44 (6), 467-472, 2008
652008
MEK wars, a new front in the battle against cancer
NS Duesbery, CP Webb, GF Vande Woude
Nature medicine 5 (7), 736-737, 1999
631999
Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis
WPD Hendricks, V Zismann, K Sivaprakasam, C Legendre, K Poorman, ...
PLoS genetics 14 (9), e1007589, 2018
582018
Xp38γ/SAPK3 promotes meiotic G2/M transition in Xenopus oocytes and activates Cdc25C
E Perdiguero, MJ Pillaire, JF Bodart, F Hennersdorf, M Frödin, ...
The EMBO journal, 2003
582003
Systemic anthrax lethal toxin therapy produces regressions of subcutaneous human melanoma tumors in athymic nude mice
RJ Abi-Habib, R Singh, SH Leppla, JJ Greene, Y Ding, B Berghuis, ...
Clinical cancer research 12 (24), 7437-7443, 2006
572006
Mitogen-activated protein kinase kinase signaling promotes growth and vascularization of fibrosarcoma
Y Ding, EA Boguslawski, BD Berghuis, JJ Young, Z Zhang, K Hardy, ...
Molecular cancer therapeutics 7 (3), 648-658, 2008
532008
LRP5 and LRP6 Are Not Required for Protective Antigen–Mediated Internalization or Lethality of Anthrax Lethal Toxin
JJ Young, JL Bromberg-White, C Zylstra, JT Church, E Boguslawski, ...
PLoS pathogens 3 (3), e27, 2007
532007
Pathophysiology of anthrax
AE Frankel, SR Kuo, D Dostal, L Watson, NS Duesbery, CP Cheng, ...
Frontiers in bioscience (Landmark edition) 14, 4516, 2009
502009
Anthrax, MEK and cancer
JF Bodart, A Chopra, X Liang, N Duesbery
Cell Cycle 1 (1), 7-12, 2002
452002
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20